Lv2
160 积分 2023-04-09 加入
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma
8天前
已完结
Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma
1个月前
已完结
Lenalidomide arrests cell cycle and modulates PD1-dependent downstream mTOR intracellular signals in melanoma cells
1个月前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
2个月前
已完结
Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer
2个月前
已完结
Strengthening Molecular Glues: Design Strategies for Improving Thalidomide Analogs as Cereblon Effectors and Anticancer Agents
2个月前
已完结
A review on the treatment of multiple myeloma with small molecular agents in the past five years
2个月前
已完结
Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience
2个月前
已完结
Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
4个月前
已完结
Diagnosis and Management of Multiple Myeloma
4个月前
已完结
皖公网安备34019202002308
